BamSEC and AlphaSense Join Forces
Learn More

AbbVie Inc.

NYSE: ABBV    
Share price (6/12/25): $192.42    
Market cap (6/12/25): $340 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 56 pages AbbVie Inc. Supplemental Indenture No. 11 $1,250,000,000 4.650% Senior Notes Due 2028 $1,000,000,000 4.875% Senior Notes Due 2030 $1,000,000,000 5.200% Senior Notes Due 2035 $750,000,000 5.600% Senior Notes Due 2055
12/34/56
EX-4.1
from 10-K 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-8 19 pages Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan
12/34/56
EX-4.9
from 8-K 11 pages Abbvie Inc. 5.500% Senior Notes Due 2064
12/34/56
EX-4.8
from 8-K 11 pages Abbvie Inc. 5.400% Senior Notes Due 2054
12/34/56
EX-4.7
from 8-K 11 pages Abbvie Inc. 5.350% Senior Notes Due 2044
12/34/56
EX-4.6
from 8-K 11 pages Abbvie Inc. 5.050% Senior Notes Due 2034
12/34/56
EX-4.5
from 8-K 11 pages Abbvie Inc. 4.950% Senior Notes Due 2031
12/34/56
EX-4.4
from 8-K 11 pages Abbvie Inc. 4.800% Senior Notes Due 2029
12/34/56
EX-4.3
from 8-K 11 pages Abbvie Inc. 4.800% Senior Notes Due 2027
12/34/56
EX-4.2
from 8-K 12 pages Abbvie Inc. Supplemental Indenture No. 10
12/34/56
EX-4.5
from S-8 22 pages Immunogen, Inc. Inducement Equity Incentive Plan, as Amended
12/34/56
EX-4.4
from S-8 23 pages Immunogen, Inc. Amended and Restated 2018 Employee, Director and Consultant Equity Incentive Plan
12/34/56
EX-4.1
from 10-K 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-Q 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 21 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.8
from S-8 3 pages Fifth Amendment to the Allergan, Inc. Retirement 401(k) Plan
12/34/56
EX-4.7
from S-8 2 pages Fourth Amendment to the Allergan, Inc. Retirement 401(k) Plan
12/34/56